Glenmark Pharma submits NDA application for Ryaltris
Ryaltris is for seasonal allergic rhinitis and it is formerly known as GSP 301 nasal spray, and it is the company’s leading…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Barriers impede biosimilar market entry into the US despite BPCIA: GlobalData
There are only nine biosimilars available on the US market to date and it is estimated that only three per cent of spending on…
Cadila Healthcare and Sun Pharma receive 2018 India Innovation Conference & Awards
Organised by Clarivate Analytics, it honours India’s most disruptive innovators
Glenmark gets ANDA approval for Colesevelam Hydrochloride Tablets, 625 mg
The company has already commenced supplies of the product to the US market
It’s serialisation – Just not as you know it
If Indian pharma firms are to continue to manufacture and export internationally, then they must start taking a hard look at the…
Pharma companies – using digital to create connections and customer value
Life sciences companies now have a new source of competitive advantage. – use digital to build direct relationships with customers…
DCGI to mandate separate rack for generics in pharmacies
CDSCO website will release a notification about the new provision for sale of medicines in India
Patients First!
Currently less than 1.3 per cent of clinical trials conducted in the world are in India. There is a need to ensure more drug…
Indoco facilities bag US FDA nod
Manufacturing facilities at Patalganga and Rabale were inspected successfully